• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of adjunctive use of guide extension catheter on midterm outcome of drug-coated balloon angioplasty.

作者信息

Yoshida Ruka, Ishii Hideki, Morishima Itsuro, Tanaka Akihito, Takagi Kensuke, Iwakawa Naoki, Tashiro Hiroshi, Kojima Hiroki, Mitsuda Takayuki, Hirayama Kenshi, Hitora Yusuke, Furusawa Kenji, Murohara Toyoaki

机构信息

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

EuroIntervention. 2019 Oct 20;15(8):688-691. doi: 10.4244/EIJ-D-18-01013.

DOI:10.4244/EIJ-D-18-01013
PMID:30636685
Abstract
摘要

相似文献

1
Impact of adjunctive use of guide extension catheter on midterm outcome of drug-coated balloon angioplasty.辅助使用导引导管延长导管对药物涂层球囊血管成形术中期结果的影响。
EuroIntervention. 2019 Oct 20;15(8):688-691. doi: 10.4244/EIJ-D-18-01013.
2
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果：PEPCAD-DES 研究的见解（使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄）。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
3
Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.紫杉醇涂层球囊导管治疗冠状动脉支架内再狭窄的长期随访。
JACC Cardiovasc Interv. 2012 Mar;5(3):323-30. doi: 10.1016/j.jcin.2012.01.008.
4
Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis.药物涂层球囊血管成形术治疗支架内再狭窄中优化操作相关因素的影响。
JACC Cardiovasc Interv. 2018 May 28;11(10):969-978. doi: 10.1016/j.jcin.2018.02.002.
5
REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.紫杉醇涂层球囊血管成形术与药物洗脱支架在急性心肌梗死中的血管重建比较——一项随机对照试验：REVELATION试验的原理与设计
Catheter Cardiovasc Interv. 2016 Jun;87(7):1213-21. doi: 10.1002/ccd.26241. Epub 2015 Sep 15.
6
Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.即刻无波比比值指导紫杉醇涂层球囊治疗新发冠状动脉病变。
Int J Cardiovasc Imaging. 2020 Feb;36(2):179-185. doi: 10.1007/s10554-019-01707-5. Epub 2019 Oct 9.
7
Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.使用紫杉醇涂层球囊且不植入支架的血流储备分数引导下冠状动脉血管成形术：血管造影和光学相干断层扫描评估的可行性、安全性及6个月结果
Clin Res Cardiol. 2017 Jan;106(1):18-27. doi: 10.1007/s00392-016-1019-4. Epub 2016 Jul 5.
8
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes.SABRE 试验（西罗莫司血管成形术球囊治疗冠状动脉支架内再狭窄）：血管造影结果和 1 年临床结果。
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2029-2037. doi: 10.1016/j.jcin.2017.06.021. Epub 2017 Sep 27.
9
Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.药物涂层球囊治疗冠状动脉支架内再狭窄
JACC Cardiovasc Interv. 2019 Mar 25;12(6):558-566. doi: 10.1016/j.jcin.2018.11.040.
10
Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry.新型西罗莫司涂层球囊在复杂经皮冠状动脉介入治疗中的即刻和短期性能。法特贝纳通西罗莫司涂层球囊（FASICO）注册研究。
Cardiovasc Revasc Med. 2017 Oct-Nov;18(7):487-491. doi: 10.1016/j.carrev.2017.03.025. Epub 2017 Mar 25.

引用本文的文献

1
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.用于冠状动脉疾病的药物涂层球囊：从理论到实践
Curr Treat Options Cardiovasc Med. 2025 Dec;27(1). doi: 10.1007/s11936-025-01084-4. Epub 2025 Mar 19.
2
[Safety and efficacy of the Essential Pro paclitaxel drug-eluting balloon for the treatment of coronary in-stent restenosis].爱施健紫杉醇药物洗脱球囊治疗冠状动脉支架内再狭窄的安全性和有效性
REC Interv Cardiol. 2024 Jul 12;6(3):166-171. doi: 10.24875/RECIC.M24000462. eCollection 2024 Jul-Sep.
3
Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics.
日本心血管介入治疗学会药物涂层球囊治疗冠状动脉疾病临床专家共识文件
Cardiovasc Interv Ther. 2023 Apr;38(2):166-176. doi: 10.1007/s12928-023-00921-2. Epub 2023 Feb 27.
4
Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans.虚拟现实辅助经皮腔内血管成形术治疗下肢动脉硬化闭塞症。
J Healthc Eng. 2021 Jul 27;2021:9975583. doi: 10.1155/2021/9975583. eCollection 2021.
5
Differences in primary indication for guide-extension catheter usage among the three target vessels.三种目标血管在使用导引导管延长导管的主要适应症方面的差异。
Postepy Kardiol Interwencyjnej. 2020 Jun;16(2):192-197. doi: 10.5114/aic.2020.96063. Epub 2020 Jun 23.